The new German evidence-based guideline on diffuse large B-cell lymphoma-key aspects for radiation oncologists.
Michael OertelChristian BerdelGerhard HeldKlaus HerfarthHeinz SchmidbergerMoritz ErnstGeorg LenzPeter BorchmannHans Theodor EichPublished in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2023)
RT remains an integral part of the treatment repertoire of DLBCL. With the use of PET-guided treatment, RT is indicated for patients with metabolically active tumors. In the context of the ongoing development of targeted therapies, new RT indications may evolve.